GPR55: A novel cannabinoid receptor involved in the regulation of osteoclast function and bone mass

被引：1
|
作者：
Whyte, L. [1 ]
Ryberg, E. [2 ]
Sims, N. A. [3 ]
Ridge, S. [1 ]
Mackie, K. [4 ]
Greasley, P. [2 ]
Ross, R. A. [1 ]
Rogers, M. J. [1 ]
机构：
[1] Univ Aberdeen, Sch Med & Med Sci, Aberdeen, Scotland
[2] AstraZeneca R & D, Dept Lead Generat, Molndal, Sweden
[3] St Vincents Inst, Fitzroy, Vic, Australia
[4] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA
来源：
BONE | 2009年 / 44卷
关键词：
D O I：
10.1016/j.bone.2009.01.305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
391
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [21] Activation of the Novel Cannabinoid Receptor, GPR55, Mediates the Antiproliferative Effects of Anandamide on Cholangiocarcinoma Growth
    Ramirez, Jonathan
    Frampton, Gabriel A.
    Brennan, Andrew
    Huang, Li
    Mohamad, Akimuddin
    DeMorrow, Sharon
    GASTROENTEROLOGY, 2010, 138 (05) : S792 - S792
  • [22] The novel cannabinoid receptor GPR55 binds atypical cannabinoids but does not mediate their vasodilatory effects
    Johns, Douglas G.
    Behm, David J.
    Ao, Zhaohui
    Walker, Debbie
    Parsons, Michael
    Senadhi, Shobha
    T Goserud, Matthew
    Daniels, Dion A.
    Riddick, Michelle
    Staton, Penelope C.
    Green, Paula
    Bao, Welke
    Aiyar, Nambi
    Yue, Tian-Li
    Brown, Andrew J.
    Morrison, Alastair D.
    Douglas, Stephen A.
    HYPERTENSION, 2006, 48 (04) : E86 - E86
  • [23] IS GPR55 AN ANANDAMIDE RECEPTOR?
    Brown, Andrew J.
    Hiley, C. Robin
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 111 - 137
  • [24] The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
    R Piñeiro
    T Maffucci
    M Falasca
    Oncogene, 2011, 30 : 142 - 152
  • [25] An investigation into the role of the putative cannabinoid receptor GPR55 in regulating neuroinflammation and neurodegeneration
    Haugh, Orla
    O'Brien, Aislinn L.
    Irving, Andrew J.
    Campbell, Veronica A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S178 - S179
  • [26] The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
    Sharir, Haleli
    Console-Bram, Linda
    Mundy, Christina
    Popoff, Steven N.
    Kapur, Ankur
    Abood, Mary E.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 (04) : 856 - 865
  • [27] Optimization of synthetically novel agonists of the putative cannabinoid receptor, GPR55, using an activated state model
    Lingerfelt, Mary
    Alfakhori, Lara
    Hurst, Dow
    Zhao, Pingwei
    Croatt, Mitch
    Abood, Mary
    Reggio, Patricia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [28] The putative cannabinoid receptor GPR55 participates in the control of cancer cell proliferation
    Andradas, C.
    Caffarel, M. M.
    Salazar, M.
    Perez-Gomez, E.
    Lorente, M.
    Velasco, G.
    Guzman, M.
    Sanchez, C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 91 - 91
  • [29] Optimization of Synthetically Novel Agonists of the Putative Cannabinoid Receptor, GPR55, using an Activated State Model
    Lingerfelt, Mary A.
    Zhao, Pingwei
    Fakhouri, Lara
    Abood, Mary E.
    Croatt, Mitchell P.
    Reggio, Patricia H.
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 415A - 415A
  • [30] GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
    Lauckner, Jane E.
    Jensen, Jill B.
    Chen, Huei-Ying
    Lu, Hui-Chen
    Hille, Bertil
    Mackie, Ken
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (07) : 2699 - 2704
12345